These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16154354)

  • 1. Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs.
    Spina C; Tangpricha V; Yao M; Zhou W; Wolfe MM; Maehr H; Uskokovic M; Adorini L; Holick MF
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):111-20. PubMed ID: 16154354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.
    Huerta S; Irwin RW; Heber D; Go VL; Koeffler HP; Uskokovic MR; Harris DM
    Cancer Res; 2002 Feb; 62(3):741-6. PubMed ID: 11830528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and cancer.
    Spina CS; Tangpricha V; Uskokovic M; Adorinic L; Maehr H; Holick MF
    Anticancer Res; 2006; 26(4A):2515-24. PubMed ID: 16886659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice.
    Tangpricha V; Spina C; Yao M; Chen TC; Wolfe MM; Holick MF
    J Nutr; 2005 Oct; 135(10):2350-4. PubMed ID: 16177194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Gemini analogs of 1alpha,25-dihydroxyvitamin D(3) with enhanced transcriptional activity.
    Weyts FA; Dhawan P; Zhang X; Bishop JE; Uskokovic MR; Ji Y; Studzinski GP; Norman AW; Christakos S
    Biochem Pharmacol; 2004 Apr; 67(7):1327-36. PubMed ID: 15013848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancer.
    Irving AA; Plum LA; Blaser WJ; Ford MR; Weng C; Clipson L; DeLuca HF; Dove WF
    J Nutr; 2015 Feb; 145(2):291-8. PubMed ID: 25644350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat.
    Sitrin MD; Halline AG; Abrahams C; Brasitus TA
    Cancer Res; 1991 Oct; 51(20):5608-13. PubMed ID: 1913678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR; Schwartz AM; Shchepotin EI; Uskokovic M; Shchepotin IB
    Clin Cancer Res; 1998 Nov; 4(11):2869-76. PubMed ID: 9829754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of vitamin D deficiency on cancers and autoimmune diseases development].
    Kuryłowicz A; Bednarczuk T; Nauman J
    Endokrynol Pol; 2007; 58(2):140-52. PubMed ID: 17578830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D.
    Holt PR; Arber N; Halmos B; Forde K; Kissileff H; McGlynn KA; Moss SF; Kurihara N; Fan K; Yang K; Lipkin M
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):113-9. PubMed ID: 11815408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.
    Albert DM; Kumar A; Strugnell SA; Darjatmoko SR; Lokken JM; Lindstrom MJ; Patel S
    Arch Ophthalmol; 2004 Sep; 122(9):1357-62. PubMed ID: 15364716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective role of dietary vitamin D3 in rat colon carcinogenesis.
    Mokady E; Schwartz B; Shany S; Lamprecht SA
    Nutr Cancer; 2000; 38(1):65-73. PubMed ID: 11341047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
    J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.
    Murillo G; Mehta RG
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):129-36. PubMed ID: 16051482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dietary antioxidants combined with a chemotherapeutic agent on human colon cancer progression in a fluorescent orthotopic mouse model.
    Ma H; Das T; Pereira S; Yang Z; Zhao M; Mukerji P; Hoffman RM
    Anticancer Res; 2009 Jul; 29(7):2421-6. PubMed ID: 19596909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.